I.C.P. Israel Citrus Plantations Ltd (CTPL1) fair value: what the stock is really worth
As of Sep 17, 2026: fair value of I.C.P. Israel Citrus Plantations Ltd ILS 36.60, price ILS 250, upside -85.4%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Structural break:
The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.
Stretched ValuationStrong overvaluation with only moderate quality.
!Fair value 36.60 ILA · Strongly overvalued (−85%)
!Quality 54/100
!Weak Growth(revenue 5y +0.8 %/yr)
!Low debt · negative free cash flow
!Mixed vs. peers(5/10)
!Moderate moat58/100
!Insider activity35/100
!Evidence only low, so the estimate is less certain
Watch I.C.P. Israel Citrus Plantations Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range 199.50 ILA – 352.60 ILA · fair‑value band 27.45 ILA – 45.75 ILA · the 250.00 ILA price screens above the 36.60 ILA fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow I.C.P. Israel Citrus Plantations in your weekly email
Every Wednesday you see whether I.C.P. Israel Citrus Plantations is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
I.C.P. Israel Citrus Plantations Ltd. provides agricultural services in Israel. The company operates in two segments, Agriculture and Income-Producing Properties.
Show more
I.C.P. Israel Citrus Plantations Ltd. provides agricultural services in Israel. The company operates in two segments, Agriculture and Income-Producing Properties. It provides agricultural services, which includes planting, maintaining, and cultivating orchards as well as fertilization, irrigation, pest control and spraying, replanting, and harvest and orchard management. The company engages in planning, development, leasing, and management of land and buildings. It sells its products to packing houses. The company was incorporated in 1958 and is based in Tel Aviv-Yafo, Israel.
Stock analysis
I.C.P. Israel Citrus Plantations Ltd (CTPL1) currently trades at 250.00 ILA, while our model-based Fair Value estimate is 36.60 ILA, implying the stock looks roughly 583.1% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 8 models at a data quality of 94/100, which puts the evidence level at low.
Scenario range: 27.45 ILA (bear) to 45.75 ILA (bull), the price of 250.00 ILA sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Real Estate sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
I.C.P. Israel Citrus Plantations Ltd reported revenue of 1.1M ILS in FY2025 versus 1.1M ILS in FY2021, a compound 0.0%/yr. Reported net income was 38.0M ILS in FY2025, compounding +44.4%/yr from FY2021.
Key figures
Market cap 62.4M ILA · P/E ratio 1.5 · P/S ratio 52.2 · EPS (TTM) 152.06 ILA · Net margin 3,505% · Return on equity 42.7% · Return on assets (EBIT) 4.9% · Operating margin −193%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 7% below its 52-week high and 25% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −37% fair-value upside, at −85%, CTPL1 screens richer than that median.
Fair Value models
Bear 27.45 ILAFair Value 36.60 ILABull 45.75 ILA
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (111.65 ILS per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.31/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−1.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.8%
Start year 2020 (pandemic). Over 10 years: +1.2% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.0%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+40.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+40.8%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.60% vs 34%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.379% → −155%
2025 sits 935% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Compare I.C.P. Israel Citrus Plantations Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 547 stocks
Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score54 · Below median
Fair Value upside−85% · Bottom 25%
Profitability
Return on equity (TTM)43% · Top 25%
Return on assets16% · Top 25%
Operating margin (TTM)−193% · Bottom 25%
Growth and dividend
Revenue growth0% · Below median
Valuation Multiplesvs Real Estate Services median · lower = cheaper
P/E (TTM)1.5× · Cheapest 25%
P/B0.19× · Cheapest 25%
P/S (TTM)18.91× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 37
FUTURE (revenue growth)0· sector 12
PAST (return on equity)100· sector 16
HEALTH (low debt)100· sector 83
DIVIDEND (yield)0· sector 65
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "I.C.P. Israel Citrus Plantations Ltd Fair Value". https://www.fairvalue-calculator.com/stock/CTPL1
Frequently asked questions
Is I.C.P. Israel Citrus Plantations Ltd (CTPL1) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 36.60 ILA versus the last price from Sep 17, 2026 of 250.00 ILA, about −85% upside (overvalued).
What is the fair value of CTPL1?
Our model-based fair value for I.C.P. Israel Citrus Plantations Ltd is 36.60 ILA (as of Sep 23, 2026), built from audited fundamentals. Last price (from Sep 17, 2026): 250.00 ILA.
What is the quality score of CTPL1?
I.C.P. Israel Citrus Plantations Ltd has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
Our model-based price target is the fair value of 36.60 ILA (as of Sep 23, 2026) from 4 valuation models. Cautious scenario 27.45 ILA, optimistic scenario 45.75 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the I.C.P. Israel Citrus Plantations Ltd stock forecast for 2026?
Our models put fair value at 36.60 ILA, about −85% upside versus the last price from Sep 17, 2026 of 250.00 ILA (overvalued). Cautious scenario 27.45 ILA, optimistic scenario 45.75 ILA. The calculation is refreshed regularly with new filings.
What is the revenue of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
I.C.P. Israel Citrus Plantations Ltd reported trailing-twelve-month revenue of about 1.1M ILS (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For I.C.P. Israel Citrus Plantations Ltd it is 36.60 ILA per share (as of Sep 23, 2026), against a price of 250.00 ILA. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is I.C.P. Israel Citrus Plantations Ltd stock overvalued or undervalued in 2026?
As of Sep 23, 2026, CTPL1 trades above its calculated fair value: price 250.00 ILA, fair value 36.60 ILA, a gap of about −85% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CTPL1?
No. The price is what the market pays today (250.00 ILA); the fair value is what the company's own numbers justify (36.60 ILA). For I.C.P. Israel Citrus Plantations Ltd the two are 213.40 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is I.C.P. Israel Citrus Plantations Ltd worth?
The market values I.C.P. Israel Citrus Plantations Ltd at about 62.4M ILA (market capitalisation, as of Sep 23, 2026). Per share that is 250.00 ILA; our models calculate a fair value of 36.60 ILA per share.
What do the bullish and bearish scenarios say about CTPL1?
Our models span a range for I.C.P. Israel Citrus Plantations Ltd: cautious scenario 27.45 ILA, base 36.60 ILA, optimistic 45.75 ILA per share (as of Sep 23, 2026, price 250.00 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CTPL1?
I.C.P. Israel Citrus Plantations Ltd trades at a price-to-earnings ratio of 1.5 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 36.60 ILA is built from several models across several years. Other multiples: P/B 0.2, P/S 18.9.
How solid is the balance sheet of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
Balance-sheet figures for I.C.P. Israel Citrus Plantations Ltd (as of Sep 23, 2026): return on equity 42.7%. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is CTPL1 from its 52-week high?
I.C.P. Israel Citrus Plantations Ltd trades at 250.00 ILA, about 7% below its 52-week high of 270.00 ILA and 25% above the low of 199.50 ILA (as of Sep 17, 2026). Distance from the high says nothing about value: that is what the fair value of 36.60 ILA is for.
Which stocks are comparable to I.C.P. Israel Citrus Plantations Ltd?
From the same area (Real Estate) we also value Vingroup Joint Stock Company, CBRE Group, Vonovia SE, Cellnex Telecom, S.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is I.C.P. Israel Citrus Plantations Ltd stock attractive at the current price?
The data as of Sep 23, 2026: price 250.00 ILA, calculated fair value 36.60 ILA (−85%), Quality Score 54/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CTPL1 calculated?
We run I.C.P. Israel Citrus Plantations Ltd through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 36.60 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. I.C.P. Israel Citrus Plantations Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
The latest price we hold is from Sep 17, 2026 and stands at 250.00 ILA. Our model-based fair value is 36.60 ILA, about −85% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with I.C.P. Israel Citrus Plantations Ltd right now?
The price sits above even our optimistic bull case (45.75 ILA). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Key figures of I.C.P. Israel Citrus Plantations Ltd
How large is the market capitalisation of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
The market capitalisation of I.C.P. Israel Citrus Plantations Ltd is 62.4M ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
The price-to-sales ratio of I.C.P. Israel Citrus Plantations Ltd is 52.2 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
Earnings per share at I.C.P. Israel Citrus Plantations Ltd are 152.06 ILA (price ÷ EPS = P/E 1.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
The net margin of I.C.P. Israel Citrus Plantations Ltd is 3,505% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
The return on equity (ROE) of I.C.P. Israel Citrus Plantations Ltd is 42.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
On an EBIT basis the return on assets of I.C.P. Israel Citrus Plantations Ltd is 4.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
The operating margin of I.C.P. Israel Citrus Plantations Ltd is −193% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
Revenue at I.C.P. Israel Citrus Plantations Ltd is growing −0.2% versus a year earlier (3y avg +1.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at I.C.P. Israel Citrus Plantations Ltd (CTPL1)?
Earnings per share at I.C.P. Israel Citrus Plantations Ltd are growing +51.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does I.C.P. Israel Citrus Plantations Ltd (CTPL1) generate?
The free cash flow of I.C.P. Israel Citrus Plantations Ltd is −2.0M ILA (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does I.C.P. Israel Citrus Plantations Ltd (CTPL1) hold?
I.C.P. Israel Citrus Plantations Ltd holds more cash than debt, 11.4M ILA net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch I.C.P. Israel Citrus Plantations Ltd in the live analysis
One click puts I.C.P. Israel Citrus Plantations Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
